Intellia Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2015 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Intellia Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2015 to 2023.
  • Intellia Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $39.6M, a 12.1% increase year-over-year.
  • Intellia Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $150M, a 21.1% increase year-over-year.
  • Intellia Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $134M, a 46.7% increase from 2022.
  • Intellia Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $91.4M, a 94.4% increase from 2021.
  • Intellia Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $47M, a 136% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $134M +$42.7M +46.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-22
2022 $91.4M +$44.4M +94.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-22
2021 $47M +$27.1M +136% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-22
2020 $19.9M +$4.81M +31.9% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-23
2019 $15.1M -$1.96M -11.5% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 $17M +$1.72M +11.3% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-26
2017 $15.3M +$8.61M +128% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 $6.72M +$5.41M +413% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-27
2015 $1.31M Jan 1, 2015 Dec 31, 2015 10-K 2018-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.